While the exact mechanisms contributing to antipsychotic-induced metabolic changes are unknown, research is ongoing to pinpoint the mechanisms at play. Overall, appropriate monitoring, reporting, and patient and clinician awareness are critical to the early recognition and treatment of antipsychotic-induced DM.